NAYA Biosciences, Inc.
NAYA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $1,637 | $1,686 | $1,433 | $1,837 |
| % Growth | -2.9% | 17.6% | -22% | – |
| Cost of Goods Sold | $1,045 | $957 | $988 | $862 |
| Gross Profit | $592 | $729 | $445 | $975 |
| % Margin | 36.2% | 43.2% | 31% | 53.1% |
| R&D Expenses | $266 | $485 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,554 | $3,476 | $1,515 | $2,648 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $14,880 | $743 | $230 | $230 |
| Operating Expenses | $17,700 | $4,704 | $1,745 | $2,878 |
| Operating Income | -$17,107 | -$3,976 | -$1,300 | -$1,903 |
| % Margin | -1,044.9% | -235.8% | -90.7% | -103.6% |
| Other Income/Exp. Net | -$296 | $298 | -$301 | -$342 |
| Pre-Tax Income | -$17,404 | -$3,678 | -$1,601 | -$2,245 |
| Tax Expense | $0 | -$54 | $29 | $0 |
| Net Income | -$17,404 | -$3,623 | -$1,631 | -$2,245 |
| % Margin | -1,063% | -214.9% | -113.8% | -122.2% |
| EPS | -56.22 | -9.04 | -5.04 | -0.622 |
| % Growth | -521.9% | -79.4% | -710.3% | – |
| EPS Diluted | -56.22 | -9.04 | -5.04 | -0.622 |
| Weighted Avg Shares Out | 310 | 310 | 324 | 3,610 |
| Weighted Avg Shares Out Dil | 310 | 310 | 324 | 3,610 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $311 | $232 | $274 | $370 |
| Depreciation & Amortization | $234 | $232 | $230 | $230 |
| EBITDA | -$16,858 | -$3,214 | -$1,097 | -$1,645 |
| % Margin | -1,029.7% | -190.6% | -76.6% | -89.6% |